Electra Therapeutics Raises $183M in Series C Led by Nextech and EQT Life Sciences

Deal Summary

Electra Therapeutics, a clinical-stage biotech focused on immunology and cancer therapies, raised $183M in a Series C round co-led by Nextech and EQT Life Sciences. New investors Sanofi, HBM Healthcare Investments and Mubadala Capital participated alongside existing backers.